These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

588 related items for PubMed ID: 22774396

  • 21. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.
    Gerli S, Mignosa M, Di Renzo GC.
    Eur Rev Med Pharmacol Sci; 2003; 7(6):151-9. PubMed ID: 15206484
    [Abstract] [Full Text] [Related]

  • 22. Potential role and therapeutic interests of myo-inositol in metabolic diseases.
    Croze ML, Soulage CO.
    Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390
    [Abstract] [Full Text] [Related]

  • 23. Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS.
    Facchinetti F, Bizzarri M, Benvenga S, D'Anna R, Lanzone A, Soulage C, Di Renzo GC, Hod M, Cavalli P, Chiu TT, Kamenov ZA, Bevilacqua A, Carlomagno G, Gerli S, Oliva MM, Devroey P.
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():72-76. PubMed ID: 26479434
    [Abstract] [Full Text] [Related]

  • 24. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
    Pizzo A, Laganà AS, Barbaro L.
    Gynecol Endocrinol; 2014 Mar; 30(3):205-8. PubMed ID: 24351072
    [Abstract] [Full Text] [Related]

  • 25. d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS.
    Cianci A, Panella M, Fichera M, Falduzzi C, Bartolo M, Caruso S.
    Gynecol Endocrinol; 2015 Jun; 31(6):483-6. PubMed ID: 25893270
    [Abstract] [Full Text] [Related]

  • 26. Metabolic and hormonal effects of a combined Myo-inositol and d-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS).
    Januszewski M, Issat T, Jakimiuk AA, Santor-Zaczynska M, Jakimiuk AJ.
    Ginekol Pol; 2019 Jun; 90(1):7-10. PubMed ID: 30756365
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open-label study.
    Kachhawa G, Senthil Kumar KV, Kulshrestha V, Khadgawat R, Mahey R, Bhatla N.
    Int J Gynaecol Obstet; 2022 Aug; 158(2):278-284. PubMed ID: 34624138
    [Abstract] [Full Text] [Related]

  • 28. The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study.
    La Marca A, Grisendi V, Dondi G, Sighinolfi G, Cianci A.
    Gynecol Endocrinol; 2015 Jan; 31(1):52-6. PubMed ID: 25268566
    [Abstract] [Full Text] [Related]

  • 29. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.
    Laganà AS, Garzon S, Casarin J, Franchi M, Ghezzi F.
    Trends Endocrinol Metab; 2018 Nov; 29(11):768-780. PubMed ID: 30270194
    [Abstract] [Full Text] [Related]

  • 30. Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives.
    Paul C, Laganà AS, Maniglio P, Triolo O, Brady DM.
    Gynecol Endocrinol; 2016 Jun; 32(6):431-8. PubMed ID: 26927948
    [Abstract] [Full Text] [Related]

  • 31. Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity.
    Villeneuve MC, Ostlund RE, Baillargeon JP.
    Metabolism; 2009 Jan; 58(1):62-8. PubMed ID: 19059532
    [Abstract] [Full Text] [Related]

  • 32. Inositol as putative integrative treatment for PCOS.
    Genazzani AD.
    Reprod Biomed Online; 2016 Dec; 33(6):770-780. PubMed ID: 27717596
    [Abstract] [Full Text] [Related]

  • 33. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H, Xing C, Zhang J, He B.
    Reprod Health; 2021 Aug 18; 18(1):171. PubMed ID: 34407851
    [Abstract] [Full Text] [Related]

  • 34. Inositols in Polycystic Ovary Syndrome: An Overview on the Advances.
    Facchinetti F, Unfer V, Dewailly D, Kamenov ZA, Diamanti-Kandarakis E, Laganà AS, Nestler JE, Soulage CO, Group of 'Inositol in PCOS and Reproduction'.
    Trends Endocrinol Metab; 2020 Jun 18; 31(6):435-447. PubMed ID: 32396844
    [Abstract] [Full Text] [Related]

  • 35. D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.
    Galazis N, Galazi M, Atiomo W.
    Gynecol Endocrinol; 2011 Apr 18; 27(4):256-62. PubMed ID: 21142777
    [Abstract] [Full Text] [Related]

  • 36. Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.
    Pacchiarotti A, Carlomagno G, Antonini G, Pacchiarotti A.
    Gynecol Endocrinol; 2016 Apr 18; 32(1):69-73. PubMed ID: 26507336
    [Abstract] [Full Text] [Related]

  • 37. Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both.
    Genazzani AD, Prati A, Marchini F, Petrillo T, Napolitano A, Simoncini T.
    Gynecol Endocrinol; 2019 Dec 18; 35(12):1088-1093. PubMed ID: 31304823
    [Abstract] [Full Text] [Related]

  • 38. Inositols in PCOS.
    Kamenov Z, Gateva A.
    Molecules; 2020 Nov 27; 25(23):. PubMed ID: 33260918
    [Abstract] [Full Text] [Related]

  • 39. The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial.
    Celentano C, Matarrelli B, Pavone G, Vitacolonna E, Mattei PA, Berghella V, Liberati M.
    J Matern Fetal Neonatal Med; 2020 Mar 27; 33(5):743-751. PubMed ID: 30558466
    [Abstract] [Full Text] [Related]

  • 40. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
    Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G.
    N Engl J Med; 1999 Apr 29; 340(17):1314-20. PubMed ID: 10219066
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.